/PRNewswire/ Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for.
Operator: Good day, and welcome to the Alexandria Real Estate Equities Second Quarter 2023 Conference Call. All participants will be in listen-only mode.
/PRNewswire/ Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for.
/PRNewswire/ Lumendi, a pioneering manufacturer of endosurgical solutions, today announced the successful completion of customer evaluations of its DiLumen.
PASADENA, Calif., July 24, 2023 /PRNewswire/ Alexandria Real Estate Equities, Inc. announced financial and operating results for the second quarter ended June 30,.